Prestige Brands Holdings (NYSE: PBH) is paying $750 million for private equity-backed Insight Pharmaceuticals, the maker of home pregnancy test product EPT.

Insight Pharmaceuticals, headquartered in Revose, Pa., sells over-the-counter products, including women's health and personal-care products such as Monistat.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.